The effect of a single dose of flunixin meglumine on shedding of inoculated bovine herpesvirus-1 in weaned calves
Journal of Veterinary Internal Medicine · 2026
DOI: 10.1093/jvimsj/aalaf030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Trey N W Neyland Iii und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Kansas State University, Manhattan, KS 66506, United States. Hauptthemen laut MEDLINE: Clonixin, Herpesvirus 1, Bovine, Virus Shedding, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kansas State University College of Veterinary Medicine Mentor Clinical, Translational Research Intramural Grant.
Abstract (Originalsprache)
Background
The effects of a Food and Drug Administration approved non-steroidal anti-inflammatory drug (NSAID) on bovine herpesvirus-1 (BHV-1) shedding in cattle has not been investigated. Hypothesis/Objectives The hypothesis of this study was that a single dose of flunixin meglumine would increase the magnitude and duration of viral shedding in calves inoculated with BHV-1. Animals Twelve, 6- to 8-week-old, commercial Holstein cross-bred steer calves purchased for research, and BHV-1 polymerase chain reaction (PCR) negative on intake (day-4).
Methods
In this randomized-control study, calves were equally divided into treatment (FM) and control (CON) groups. All calves were inoculated intranasally with approximately 4 mL of 1 × 105 TCID50 of BHV-1. Nasal swabs for BHV-1 PCR testing were collected every 24 h after inoculation. Calves in the FM group were treated with 2.2 mg/kg of flunixin meglumine intravenously once after the first BHV-1 PCR positive sample. Magnitude and duration of viral shedding between groups was compared, and a P-value of <.05 was considered significant.
Results
Least square mean of the total Log10 AUC of the FM group was 6.11 (95% CI: 4.62-7.60) and CON group was 7.49 (95% CI: 6.00-8.98). The FM group’s mean duration from initial to last positive PCR was 7.33 days ± SD: 4.41 and the CON group’s mean was 9.5 days ± SD: 5.80. Conclusions and clinical importance Intranasal inoculation with BHV-1 resulted in a wide range of shedding magnitude and duration. Flunixin meglumine administration in BHV-1 challenged calves did not result in an increase in magnitude or duration of viral shedding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Kansas State University, Manhattan, KS 66506, United States.
- Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, United States.
- Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506, United States.
- Department of Statistics, Kansas State University, Manhattan, KS 66506, United States.
ORCID-Profile: Hui Wu
Förderung
- Kansas State University College of Veterinary Medicine Mentor Clinical
- Translational Research Intramural Grant
Zitieren
APA
Neyland Iii, T. N. W., Weaver, L. F., Apley, M. D., Lubbers, B. V., Pogranichniy, R. M., & Wu, H. (2026). The effect of a single dose of flunixin meglumine on shedding of inoculated bovine herpesvirus-1 in weaned calves. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalaf030
Vancouver
Neyland Iii TNW, Weaver LF, Apley MD, Lubbers BV, Pogranichniy RM, Wu H. The effect of a single dose of flunixin meglumine on shedding of inoculated bovine herpesvirus-1 in weaned calves. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalaf030
BibTeX
@article{NeylandIii2026,
author = {Neyland Iii, Trey N W and Weaver, Leslie F and Apley, Michael D and Lubbers, Brian V and Pogranichniy, Roman M and Wu, Hui},
title = {The effect of a single dose of flunixin meglumine on shedding of inoculated bovine herpesvirus-1 in weaned calves},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
doi = {10.1093/jvimsj/aalaf030}
}
EUVIMED